Phase
Condition
Metabolic Syndrome
Weight Loss
Gastroesophageal Reflux Disease (Gerd)
Treatment
Endoscopic SASI
Clinical Study ID
Ages 21-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Subject must meet all the inclusion criteria to participate in this study and list each criterion.
Age: 21-65 years
Patients going for LSG at participating hospitals.
Able to provide informed consent
Individuals below age 21 would not be recruited as this is a study in the adult population. Individuals above age 65 are excluded to minimize the procedure risk.
Exclusion
Exclusion Criteria:
Patients who were breast feeding or pregnant
Severe psychiatric illness
Eating disorder
Active neoplastic disease
End-stage renal disease
Patients with bleeding diathesis
Patients with pacemakers or implantable cardiac defibrillators
Significant cardiovascular disease (e.g., acute myocardial infarction, congestivecardiac failure, ischemic heart disease, atrial fibrillation, sick sinus syndrome,supraventricular tachycardia)
Any factors likely to limit adherence to study protocol (e.g., dementia; alcohol orsubstance abuse; history of unreliability in medication taking or appointmentkeeping; significant concerns about participation in the study from spouse,significant other or family members)
Treatment with anti-platelet agents that could not be temporarily discontinued
Study Design
Study Description
Connect with a study center
Changi General Hospital
Singapore,
SingaporeActive - Recruiting
Sengkang General Hospital
Singapore,
SingaporeActive - Recruiting
Singapore General Hospital
Singapore,
SingaporeActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.